Deutsche Bank’s Corbus Pharmaceuticals CRBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-7,045
| Closed | -$37.4K | – | 3599 |
|
|
2025
Q1 | $37.4K | Sell |
7,045
-1,161
| -14% | -$6.17K | ﹤0.01% | 3387 |
|
|
2024
Q4 | $96.8K | Buy |
8,206
+2,616
| +47% | +$30.9K | ﹤0.01% | 3250 |
|
|
2024
Q3 | $115K | Buy |
5,590
+1,416
| +34% | +$29.2K | ﹤0.01% | 3125 |
|
|
2024
Q2 | $189K | Buy |
+4,174
| New | +$189K | ﹤0.01% | 2800 |
|
|
2021
Q3 | – | Sell |
-1,800
| Closed | -$98K | – | 4234 |
|
|
2021
Q2 | $98K | Sell |
1,800
-457
| -20% | -$24.9K | ﹤0.01% | 4056 |
|
|
2021
Q1 | $134K | Buy |
2,257
+412
| +22% | +$24.5K | ﹤0.01% | 3778 |
|
|
2020
Q4 | $70K | Buy |
1,845
+501
| +37% | +$19K | ﹤0.01% | 3931 |
|
|
2020
Q3 | $72K | Buy |
1,344
+232
| +21% | +$12.4K | ﹤0.01% | 3635 |
|
|
2020
Q2 | $280K | Buy |
1,112
+335
| +43% | +$84.4K | ﹤0.01% | 2917 |
|
|
2020
Q1 | $122K | Buy |
777
+62
| +9% | +$9.74K | ﹤0.01% | 3126 |
|
|
2019
Q4 | $117K | Buy |
715
+159
| +29% | +$26K | ﹤0.01% | 3446 |
|
|
2019
Q3 | $81K | Sell |
556
-89
| -14% | -$13K | ﹤0.01% | 3584 |
|
|
2019
Q2 | $132K | Sell |
645
-1,526
| -70% | -$312K | ﹤0.01% | 3951 |
|
|
2019
Q1 | $451K | Buy |
2,171
+181
| +9% | +$37.6K | ﹤0.01% | 3466 |
|
|
2018
Q4 | $348K | Sell |
1,990
-2,995
| -60% | -$524K | ﹤0.01% | 3496 |
|
|
2018
Q3 | $1.13M | Sell |
4,985
-3,390
| -40% | -$768K | ﹤0.01% | 3212 |
|
|
2018
Q2 | $1.27M | Buy |
8,375
+5,994
| +252% | +$908K | ﹤0.01% | 3238 |
|
|
2018
Q1 | $434K | Sell |
2,381
-1,447
| -38% | -$264K | ﹤0.01% | 3719 |
|
|
2017
Q4 | $814K | Buy |
3,828
+1,326
| +53% | +$282K | ﹤0.01% | 3282 |
|
|
2017
Q3 | $535K | Sell |
2,502
-2,543
| -50% | -$544K | ﹤0.01% | 3317 |
|
|
2017
Q2 | $952K | Buy |
5,045
+1,708
| +51% | +$322K | ﹤0.01% | 3017 |
|
|
2017
Q1 | $825K | Buy |
3,337
+4
| +0.1% | +$989 | ﹤0.01% | 2730 |
|
|
2016
Q4 | $845K | Buy |
3,333
+2,333
| +233% | +$591K | ﹤0.01% | 2774 |
|
|
2016
Q3 | $203K | Buy |
+1,000
| New | +$203K | ﹤0.01% | 3505 |
|